Oct 1 (Reuters) - Biotechnology firm Galapagos' (GLPG.AS), opens new tab board has received non-binding offers from several groups, mainly comprised of financial investors, for its cell therapy ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. IO Biotech ( (IOBT)) has shared an ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

CHENGDU, China, Sept. 22, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged ...

Arsenal Biosciences, a biotech startup based in South San Francisco, is laying off about half of its workers just a year after scoring a $325 million funding round. The cell therapy company is laying ...

Bristol Myers Squibb is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big venture capital backers and Chinese assets. Roche and Johnson ...

Zoom on Wednesday launched new products at its Zoomtopia conference, including an upgraded AI companion that can work across meeting apps, as well as the ability to add your own notes, AI-powered ...

Each morning for eight weeks, Douley Olivier dragged himself out of bed at 5 a.m. to drop his girlfriend at work so he could drive her car across Dorchester to train as a lab technician in the ...

A version of the dodo bird (Raphus cucullatus) could make a return someday soon. Colossal Biosciences announced this week several milestones in its quest to bring the extinct species back to life. On ...

Amsterdam-based boutique hotel group Sir Hotels is proud to announce the opening of Sir Devonshire Square, its first London outpost. Set within East London’s historic Devonshire Square courtyard ...

Amgen's new research campus will begin construction this month. (Rendering c/o Amgen) Thousand Oaks-based biotech giant Amgen Inc. announced this month that it plans to invest more than $600 million ...